Gimm Gilbert, Parekh Tarang, Kitsantas Panagiota
Department of Health Administration and Policy, George Mason University, United States.
Department of Health Administration and Policy, George Mason University, United States.
Addict Behav. 2023 Mar;138:107559. doi: 10.1016/j.addbeh.2022.107559. Epub 2022 Nov 25.
Public support for the legalization of marijuana (cannabis) for medical or recreational use by adults has grown rapidly over the past two decades. Given the growing prevalence and concerns about potential harms, a better understanding is needed of disparities in marijuana use among adults by disability status.
Using 2015-2019 data from the National Survey on Drug Use and Health (NSDUH), we obtained a national sample of 195,130 working-age (18-64 year) adults. Descriptive and multivariable analyses were conducted to assess the prevalence and risk factors associated with marijuana use among adults by disability status and type.
We found the prevalence of marijuana use was higher among adults with disabilities (16.6% vs 10.9%) compared to those without disabilities, and this disparity widened from 2015 to 2019. Furthermore, the odds of marijuana use varied by disability type. Specifically, adults with vision disability only (OR 1.28; 95% CI 1.14-1.44), cognitive disability only (OR 1.24; 95% CI 1.13-1.35), and those with multiple disabilities (OR 1.22; 95% CI 1.11-1.34) had higher odds of marijuana use compared to adults without any disability.
Adults with disabilities have a higher prevalence of marijuana use compared to those without disabilities. Living in a state with legalized medical marijuana also increased the odds of marijuana use. These findings can help to inform policy and public health surveillance of marijuana use in the U.S. Further studies are needed to monitor the rising prevalence of marijuana use and examine how intensity of marijuana use affects health outcomes in adults with and without disabilities.
在过去二十年中,公众对成年人将大麻用于医疗或娱乐用途合法化的支持迅速增长。鉴于大麻使用的日益普遍以及对潜在危害的担忧,需要更好地了解不同残疾状况的成年人在大麻使用方面的差异。
利用2015 - 2019年全国药物使用和健康调查(NSDUH)的数据,我们获得了195,130名工作年龄(18 - 64岁)成年人的全国样本。进行了描述性和多变量分析,以评估不同残疾状况和类型的成年人中与大麻使用相关的患病率和风险因素。
我们发现,与无残疾的成年人相比,残疾成年人中大麻使用的患病率更高(16.6%对10.9%),并且这种差异在2015年至2019年间有所扩大。此外,大麻使用的几率因残疾类型而异。具体而言,仅患有视力残疾的成年人(比值比1.28;95%置信区间1.14 - 1.44)、仅患有认知残疾的成年人(比值比1.24;95%置信区间1.13 - 1.35)以及患有多种残疾的成年人(比值比1.22;95%置信区间1.11 - 1.34)与无任何残疾的成年人相比,大麻使用的几率更高。
与无残疾的成年人相比,残疾成年人中大麻使用的患病率更高。生活在医用大麻合法化的州也会增加大麻使用的几率。这些发现有助于为美国大麻使用的政策和公共卫生监测提供信息。需要进一步研究来监测大麻使用患病率的上升,并研究大麻使用强度如何影响有残疾和无残疾成年人的健康结果。